Cosela (trilaciclib)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Cosela (trilaciclib), covering 2025-05-02 to 2025-06-08. Get the full timeline:
Most recent: Clinical Trial Update: Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLC [Phase 2]